Abstract A K17I mutation in the ANG gene encoding angiogenin has been identified in a case that we previously published as ALS with neuronal intranuclear protein inclusions (Seilhean et al. in Acta Neuropathol 108:81-87, 2004). These inclusions were immunoreactive for smooth muscle a-actin but not for angiogenin. Moreover, they were not labeled by anti-TDP-43 antibodies, while numerous cytoplasmic inclusions immunoreactive for ubiquitin, p62 and TDP-43 were detected in both oligodendrocytes and neurons in various regions of the central nervous system. In addition, expression of smooth muscle a-actin was increased in the liver where severe steatosis was observed. This is the first neuropathological description of a case with an ANG mutation. Angiogenin is known to interact with actin. Like other proteins involved in ALS pathogenesis, such as senataxin, TDP-43 and FUS/TLS, it plays a role in RNA maturation.
Introduction
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder causing progressive muscle weakness due to the loss of upper and lower motor neurons. About 10% of ALS cases are familial, of these 20% are related to mutations of the Cu/Zn superoxide dismutase-1 (SOD1) gene encoding an antioxidant enzyme [50] . Other proteins implicated in the pathogenesis of ALS are the vesicletrafficking protein VAPB [37, 44] , the guanine-nucleotide exchange factor alsin [67] , senataxin that is putatively involved in DNA repair and RNA processing [6] , the 43 kDa TAR-DNA binding protein (TARDBP or TDP-43) [8, 16, 30, 52, 57, 60, 68] and recently another DNA/RNAbinding protein FUS/TLS [35, 61] . A relationship between angiogenesis and the development of ALS had been previously suggested since chronic vascular insufficiency and, possibly, insufficient VEGF-dependent neuroprotection led to motor neuron degeneration (MND) in mice [45] . This hypothesis was confirmed by the identification of mutations of ANG, encoding angiogenin, an inducer of neovascularization, in some ALS patients [14, 17, 18] .
We previously described the case of a 46-year-old woman with a rapidly progressive form of ALS which required mechanical ventilation 9 months after onset [53] . The patient had no known familial history of ALS. She died after a 4-year course. Neuropathology showed severe degeneration of the spinal cord, sparing only the posterior columns (Fig. 1a, b) , associated with neuronal loss in the substantia nigra and neuronal intranuclear inclusions (NIIs) in hippocampal pyramidal cells [53] . The NIIs were immunoreactive to ubiquitin, promyelocytic leukemia gene product (PML), ataxin-3, and proteasome 19S. They were not labeled by antibodies directed against expanded polyglutamine segments, neurofilaments, tau, synuclein, cystatin C, and were not stained by ethidium bromide [53] . These results suggested an intranuclear accumulation of an unknown protein. In addition, this patient presented with severe liver steatosis [12] .
The principal genes responsible for the adult onset form of ALS (SOD1, ANG and TARDBP, encoding SOD1, angiogenin and TDP-43 proteins, respectively) were systematically analyzed in this patient. A K17I mutation of ANG was detected. Angiogenin is a 14.1-kDa serum protein, mainly secreted by the liver in normal conditions, that belongs to the pancreatic ribonuclease A superfamily [15, 54, 63] . First identified as an angiogenic factor in tumorcell conditioned medium [15] , angiogenin has since been implicated in various functions, including development, cell survival, and RNA maturation. Angiogenin binds to actin on the surface of endothelial cells and is internalized and transported to the nucleolus [19, 25, 26] . Once in the nucleolus, angiogenin is able to act as a stress-activated ribonuclease that cleaves tRNA and inhibits protein translation [66] . Reevaluation of this case at the histological as well as immunohistochemical level including immunolabeling of angiogenin, TDP-43, p62 and known angiogenin partners or ligands in the CNS and peripheral tissues raises new questions about the pathophysiology of the disease.
Methods

Case and controls
Human tissue samples were used after consents, according to the French and European regulations.
Case
Samples of liver and peroneal muscle were taken at autopsy. The brain was sampled as previously described [53] . Blocks of the left hippocampus, embedded in paraffin after short (12 days) fixation in formalin were also available.
Controls
A normal brain, from a patient who died from pneumonia, without known neurological disease, was used as a control for immunohistochemistry. Duration of the fixation was similar in the control case and in the patient. NIIs found in diseases related to a polyglutamine expansion, including Huntington disease (n = 1) and spinocerebellar ataxia (SCA) (SCA1, n = 1; SCA3, n = 1; SCA7, n = 2) were compared to the NIIs found in this case. A case with ALS unrelated to ANG mutation, and a case with Charcot-MarieTooth disease were used as controls for severe muscle atrophy related to denervation. Liver samples taken in six other cases with severe steatosis were used as controls for the changes found in the liver in this case. Causes of death were acute pancreatitis in two cases, AIDS related CMV encephalitis, lung carcinoma, alcohol encephalopathy, myocardial infarct.
Analysis of the ANG coding sequence by direct sequencing
The genetic analyses were performed on a stored blood sample that had been obtained after the patient's formal consent for genetic analysis. Coding regions of SOD1 (5 exons), TARDBP (5 exons) and ANG (exon 1 and 2) genes were amplified in, respectively, 5, 6 and 3 fragments from genomic DNA, using primers containing home-made universal sequences at their 5 0 end (available on request), in addition to the sequence specific to the corresponding gene. The PCR products were sequenced using the universal primer pair. Forward and reverse sequence reactions were performed with the Big Dye Terminator Cycle Sequencing Ready Reaction Kit (PE Applied Biosystems Ò ). Sequence products were run on an ABI 3730 automated sequencer (PE Applied Biosystems Ò ). Data were analyzed with the Seqscape 2.5 software (Applied Biosystems Ò ).
Immunohistochemistry
After deparaffinization, the slides were immunolabeled with the antibodies listed in Table 1 . For most antibodies, the immunostaining was performed by an automate (Benchmark Ò XT Ventana Ò staining system), the slides being pre-treated by heat at 95°C in CC1 buffer, a proprietary high pH (=8) retrieval buffer (Ventana Medical Systems Ò ) ( Table 1 ). For tau and ubiquitin immunohistochemistry, the slides were pre-treated by formic acid (FA, 80%), for 5-10 min (Table 1) . Three antibodies raised against angiogenin were tested (Table 1 ). For the angiogenin and p62 antibodies, the slides were pretreated by heat (450 W) in a microwave oven during 2 9 10 min using the buffer best adapted to the pH found optimal for immunolabeling ( Table 1) .
The biotinylated secondary antibody was included in the detection kit (Ventana Ò Medical Systems Basic DAB Detection Kit 250-001 Ò ). The streptavidin-biotin-peroxidase complex was revealed by diaminobenzidine. A paraffin block of colonic adenocarcinoma was used as positive control for angiogenin and fibulin-1, the former antibody labeling tumor cells [13] and the latter, elastic fibers [48] . Placenta was used as positive control for a-actinin 1, and normal striate muscle for a-actinin 2 (Fig. 5a ).
Results
Direct sequencing of the coding sequence failed to detect any variants in both SOD1 and TARDBP in our case. In contrast, the K17I mutation was identified in the ANG gene. This mutation has already been reported as pathogenic by Wu et al. [64] .
The main neuropathological findings have been described in the previous paper [53] . The anterior and lateral tracts of the spinal cord were severely degenerated (Fig. 1a, b) . Additional sampling of the hippocampus showed focal cortical dysplasia in the left parahippocampal gyrus. Boundaries between cell layers were indistinct; the junction between deep cortical layers and white matter was ill defined. Dysmorphic neurons had abnormal orientation, surrounded by a loose and fibrillary neuropil. Among them, ballooned cells had an enlarged round soma with eccentric nucleus (Fig. 2j) . The main findings of the immunohistochemistry experiments are summarized in Table 2 . A positive labeling was obtained in control adenocarcinoma with two of the tested angiogenin antibodies (polyclonal antibody and MANG-1 monoclonal antibody). Angiogenin was immunodetected in the choroid plexus of patient and control, as well as fibulin-1 (data not shown). Intravascular monocytes were angiogenin reactive in the normal control brain (data not shown). The MANG-1 angiogenin monoclonal antibody showed, in addition, granular intracytoplasmic immunoreactivity in neurons of the controls, in all regions examined, including anterior horns of the spinal cord (Fig. 1d) . Intracytoplasmic labeling in the patient and the controls was similar (Fig. 2d ) except for a weaker staining of degenerating spinal motor neurons (Fig. 1e) . The MANG-1 angiogenin antibody also labeled reactive astrocytes (Fig. 1e, f) . This finding was not specific to the ANG mutation case, as labeled astrocytes were occasionally found in control cases in regions with reactive astrogliosis. The atrophic spinal tracts were strongly labeled (Fig. 1c) . MANG-1 immunohistochemistry did not detect any abnormal intracytoplamic or intranuclear inclusion in neurons and glial cells. No signal was detected either in smooth muscle fibers or in endothelial cells. The NIIs that were described in the previous paper were found in the pyramidal neurons of the hippocampus (Fig. 2) , and frontal cortex (medial frontal gyrus) (Fig. 3c) , as well as in dystrophic neurons in the left temporal lobe (Fig. 2j) . They were not immunolabeled by the antibodies raised against angiogenin but were immunoreactive to smA (smooth muscle alpha actin). No reactivity for smA was found in the NIIs of controls with polyglutamic inclusions. The NIIs were not immunoreactive to fibulin-1, a-actinin 1 and 2, desmin, FVIII, CD34, vimentin and TDP-43 (Fig. 2) . They were found to be immunoreactive to p62, as was expected from the previous finding of their ubiquitin positivity.
In addition, immunohistochemistry of p62 and TDP-43 revealed numerous cytoplasmic inclusions in neurons and glial cells in various regions of the CNS including hippocampus, frontal cortex, striatum, medulla and spinal cord (Fig. 3) . These cytoplasmic inclusions were not immunoreactive to smA, angiogenin, fibulin-1, a-actinin 1 and 2.
Intraneuronal, a-synuclein negative Lewy-like inclusions were detected with TDP-43 and phospho-TDP-43 antibodies in the striatum, mesencephalic tegmentum and anterior horns (Figs. 3f, 4a-c) . TDP-43 positive skein-like inclusions were observed in the anterior horn of the spinal cord and inferior olive (Fig. 3g, h ). A few ring-shape inclusions were detected in the granular cells of the dentate gyrus only with phospho-TDP43 immunohistochemistry (Fig. 4d) .
The labeled glial cells had the morphologic features characteristic of oligodendrocytes. The shapes of the inclusions were reminiscent either of the cap-shaped glial cytoplasmic inclusions (GCI) observed in multiple system atrophy (MSA) (Fig. 3c) or of the coiled bodies described in progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and argyrophilic grain disease (Fig. 3b, d ), but these inclusions, although ubiquitin positive, were tau and a-synuclein immunonegative. They were better visualized with the p62 and TDP-43 antibodies than with the phospho-TDP-43 antibody.
Major changes in immunoreactivity were also found in the peripheral organs of our case. The peroneal muscle was severely atrophied with a spectacular decrease of a-actinin-2 reactivity specifically in the Z disk (Fig. 5c ) compared to both normal (Fig. 5a ) and denervated muscle (Fig. 5b) . By contrast, detection of sarcomeric a-actin was remarkably unchanged in ANG mutation (Fig. 5f ), compared to normal (Fig. 5d) and denervated (Fig. 5e) controls.
In the patient's liver, angiogenin labeling was decreased (Fig. 6a) compared to control samples with severe steatosis (Fig. 6c) , fixed for various durations. SmA positive filaments surrounded the liver lobules forming an interconnecting network (Fig. 6b) in the patient and in one of the six control cases (which had no neurological disease history and died with acute pancreatitis). SmA positive fibers were only found in the portal and centrolobular areas in control normal liver samples and in five out of the six cases with severe steatosis (Fig. 6d) . 
Discussion
We have found that motor neuron disease associated with the K17I mutation of the ANG gene is characterized by three types of inclusions: NIIs, cytoplasmic inclusions either neuronal or oligodendroglial.
NIIs
Ubiquitin, p62, smA positive NIIs were detected in pyramidal neurons in the hippocampus and frontal cortex. The NIIs were not immunolabeled by 1C2 antibodies [53] as are those found in polyglutamine disease, or by TDP-43 antibodies as those found in other forms of ALS-dementia or in progranulin mutations. Immunoreactivity of the intranuclear inclusions to p62 is in accordance to their immunoreactivity to ubiquitin and proteasome 19S, that we had previously reported [53] . P62 immunoreactivity, contrasting with TDP-43 negativity in the NIIs observed in our case, is reminiscent of the TDP-43 negative FTLD-U recently identified [29, 39, 49] which, however, were also p62 negative [49] . Note in c, a NII (arrowhead) similar to those described in the hippocampus (Fig. 2a) Angiogenin antibodies raised against full length human protein did not label either NIIs or cytoplasmic inclusions observed in neurons and glial cells, whatever the duration of fixation. The epitope mapping of the ANG antibodies is not currently available and the possibility remains that a fragment of the protein, not recognized by these antibodies, accumulates in the NIIs. Nevertheless, the monoclonal MANG-1 antibody immunostained the cytoplasm of the neurons in all regions examined, in patient and controls, as previously described in the normal spinal cord [64] .
In our case, K17I ANG mutation was associated with a sequestration of smA in the nucleus of susceptible neurons in the frontal cortex and the hippocampus. Remarkably, these inclusions were not found in the regions where the most severe neuronal loss was observed such as the spinal cord or the substantia nigra. This suggests that NIIs are transient and occur much earlier than cell death or that they play a protective role-a role that has been documented for the NIIs observed in SCA models [2] . In many hereditary diseases, the accumulated protein is coded by the mutated gene. In the K17I ANG mutation, as in PRGN mutations the NIIs do not contain the abnormal protein [39] . In the PRGN mutations the protein is not translated because the mutant mRNAs decay rapidly [1, 40] .
Cytoplasmic inclusions
Many p62 and TDP-43 positive intracytoplasmic inclusions were found in neurons and oligodendrocytes throughout the CNS. These inclusions were not labeled by antibodies raised against angiogenin or other related proteins including smA, a-actinins and fibulin-1. Their shape and Lewy-like TDP-43 and phospho-TDP-43 neuronal cytoplasmic inclusions were found in the striatum, mesencephalic tegmentum and anterior horns. Neuronal granular cytoplasmic inclusions with absent nuclear TDP-43 labeling, similar as those observed in the hippocampus in our case, have been previously interpreted as ''pre-inclusions'' in FTLD-U [4, 9, 60] . The rarity of inclusions in the dentate gyrus, detected only by the phospho-TDP-43 antibody, was remarkable in our case.
The oligodendroglial cytoplasmic inclusions were observed in all the samples of the CNS that we examined. Some TDP-43 oligodendroglial inclusions have previously been described in the medullary tegmentum and inferior olivary nucleus [10] , as well as in the cerebral white matter in FTLD-MND [21] . They may be observed in various CNS regions in sporadic ALS cases particularly when associated to TDP-43 neuronal cytoplasmic inclusions in the dentate gyrus [43] . In the present case, they were found in numerous areas of the CNS, representing one of the predominant neuropathologic features. The presence of numerous oligodendroglial inclusions of various types is characteristic of several neurodegenerative diseases such as MSA [46] , PSP, CBD, argyrophilic grain disease [3, 33] , and more recently in white matter tauopathy with globular glial inclusions [34] . Absence of immunoreactivity of the glial inclusions to a-synuclein and tau in the present case ruled out an association with one of these diseases.
Angiogenin, which was first described as an angiogenic factor secreted by tumor cells, has several physiological roles. In culture, angiogenin promotes ribosomal RNA transcription, cellular proliferation, organization of endothelial cells into tube-like structures and supports endothelial cell migration [24, 28, 59] . A strong expression of the protein has been detected in the developing mouse nervous system as well as in post-mitotic motor neurons derived from P19 cells [58] . It is also able to modulate PI-3-kinase/Akt-1 and ERK1/2 that belong to signaling pathways involved in neuron survival [20] . Transfection of wild ANG, but not of ANG K40I mutant, protects NSC34 cells against excitotoxic injury. Angiogenin treatment, even after the clinical onset of neurologic signs, increases lifespan and motor function in SOD1 mutant mice [31] .
The dominant mode of inheritance of ALS related to angiogenin mutation favors a toxic gain of function. However, most ANG mutations identified in ALS patients are associated with functional loss of angiogenic activity [7, 64] . Six of the seven ALS-linked mutations including K17I markedly decrease the ribonuclease activity of angiogenin [7] . In contrast to mutations S28N, P112L [64] R31A and R31K [18] , impairment of the nuclear translocation has not been observed with the K17I mutation [64] .
Accumulation of actin due to the K17I ANG mutation is probably related to a disturbance of angiogenin-actin interaction. Actin is a ubiquitous molecule of the cytosol that plays a key role in cell structure, cell motility and contraction in both muscle and non-muscle cells. Mammals produce six isoforms in a tissue-specific fashion encoded by separated genes [62] and divided into three classes (a, b, c) according to their isoelectric point. Alpha-actins are found in striate and smooth muscles, whereas b and c isoforms are prominent in non-muscle cells. Both exogenous and endogenous angiogenin is able to interact with various actin isoforms. Smooth muscle a-actin has been identified as the 42-kDa angiogenin receptor protein at the surface of endothelial cells [23, 26, 41] . Actin binding to exogenous angiogenin at the surface of the cell induces membrane actin polymerization [26] . This surface interaction also induces endocytosis of angiogenin before translocation to the nucleus [42] . Actin polymerization and angiogenin endocytosis are critical steps in the process of angiogenindependent neovascularization [26, 42] . In addition, angiogenin binding to a-actin promotes Akt-1 activation [31, 32] . Akt-1 belongs to the serine/threonine-specific protein kinase family and is involved in cellular survival pathways by inhibiting apoptotic processes. It has been recently shown to play a key role in motor neuron protection in vitro and in vivo [31] .
Endogenous angiogenin is able to interact with intracellular actin, a major component of the cytoskeleton by the mediation of cytosolic a-actinin-2 [27] , which is a member of the spectrin/dystrophin superfamily [56] . Alpha-actinins form anti-parallel rod-shaped dimers that bundle actin filaments in cytoskeleton frameworks [56] . In mammalian cells four a-actinin genes produce at least six different isoforms with specific tissue type and expression profiles. In skeletal and cardiac muscle, a-actinin-2 is localized in the Z disk and cross-links anti-parallel actin filaments coming from adjacent sarcomeres [56] . In the central nervous system, a-actinin-2 is a postsynaptic protein which colocalizes in dendritic spines with the NR1 and NR2B subunits of N-methyl-D-aspartate (NMDA) glutamate receptors [11, 65] . a-Actinin-2 binds the receptors to the actin cytoskeleton the integrity of which is mandatory for their function [51] . In addition to neuronal degeneration, it is noteworthy that this patient presented with apparently asymptomatic cortical dysplasia in the left temporal lobe. Some dystrophic neurons contained intranuclear inclusions arguing for an effect of the mutation on neuronal migration.
Specific loss of a-actinin-2 in the striate muscle associated with Z disk disorganization is suggestive of a direct muscular toxicity of the mutation that could add its effect to the loss of motor neurons. The muscle deficiency may have played a role in the rapid course of the disease that led the patient to mechanical ventilation only a few months after onset.
Fatty liver disease observed in our patient was unusually severe compared to other ALS patients [12] . We do not exclude that steatosis was an incidental feature due to metabolic exogenous factors. Nevertheless, ANG mutation could influence angiogenesis and lipid metabolism in the liver. Angiogenesis plays a role in the modulation of adipogenesis [5] and angiogenin is one of the downregulated genes in the C57BL/6J mice strain characterized by a high level of hepatic triglycerides [38] . Liver is normally the site of the highest angiogenin gene expression in adult [63] although the intensity of labeling has been reported to be quite low in non-tumoral liver [22] . It was particularly low in our patient compared to controls with steatosis. More striking was the pattern of expression of smA which was compatible with an increased polymerization of a-actin. Hepatic sinusoids are normally deprived of vascular wall. They are limited by a layer of endothelial cells surrounded by stellate and Kupfer's cells, separated from hepatocytes by space of Disse. In our case there was a formation of an additional actin layer located under the endothelial cells and organized in a branching network. It has been shown that some catalytically inactive angiogenin mutants were still able to induce actin polymerization [55] . Its hypothetic role in liver regeneration or steatosis remains to be explored. The liver could be another site of angiogenin dysfunction besides the CNS and muscle in K17I ANG mutations.
TARDBP or TDP-43 is a DNA and RNA-binding protein which regulates transcription and splicing. An abnormal form of the protein, hyperphosphorylated and truncated, has been found to be accumulated in the cytoplasm, and sometimes nucleus, of neurons and glial cells in many cases of sporadic ALS and in FTLD-U. TDP-43 immunoreactivity is absent from the nucleus of cells containing cytoplasmic inclusions suggesting that pathogenesis of these proteinopathies could be due to the loss of normal TDP-43 function in the nucleus [36] . In PGRN gene mutations, causing familial FTLD-U with TDP-43 intranuclear and intracytoplasmic aggregates, genetic variability of microRNAs (miRNA) that bind mRNAs, can significantly modulate the translation of the protein, increasing the risk to develop the disease [47] . Two other genes coding for proteins involved in RNA processing have been found to be mutated in familial ALS. One is SETX coding for senataxin, which belongs to the helicase family that are involved in DNA repair and production of RNA. The other is the FUS/TLS (fusing in sarcoma/translated in liposarcoma) gene coding for another DNA/RNA binding protein [35, 61] . Analysis of the brain and spinal cords of ALS patients carrying the FUS/ TLS mutations showed intracytoplasmic neuronal aggregates reminiscent of TDP-43 aggregates [35, 61] . Detection of TDP-43 in the cytoplasm of neurons and glial cells in this case of ANG K17I mutation and recent discovery of angiogenin role in tRNA cleavage and inhibition of protein translation [66] support the hypothesis that angiogeninrelated ALS pathogenesis also involves a defect in RNA maturation.
However, in contrast to TARDBP and FUS/TLS mutations, it is not the mutated protein that accumulates in the K17I ANG mutation, but smA, probably a partner of angiogenin. Additional accumulation of TDP-43 in neurons and oligodendrocytes in cells different from those with smA positive NIIs suggests associated pathways of toxicity.
The present case, which is, to the best of our knowledge, the first neuropathology report of an ANG mutation, illustrates in several ways the toxicity related to this mutation, including alteration of neuronal and muscle fibers survival, and possible associated impairment of neuronal cell migration and lipid metabolism. Neuropathologically, the salient characteristics of the case were smA and ubiquitin positive NIIs, and TDP-43 positive oligodendroglial and neuronal cytoplasmic inclusions. The anti-smooth muscle a-actin antibody can be a useful tool for the neuropathological analysis of ALS. ANG mutations should be looked for in patients presenting with rapidly progressing ALS, as well as in patients with cortical dysplasia or unexplained severe steatosis. It is important to recognize that RNA maturation related to angiogenin, TDP-43 and FUS/TLS plays a key role in the pathogenesis of ALS.
